WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006081391) COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/081391    International Application No.:    PCT/US2006/002874
Publication Date: 03.08.2006 International Filing Date: 25.01.2006
IPC:
A61K 31/50 (2006.01), A61K 31/4965 (2006.01), A61K 31/505 (2006.01), C07D 401/00 (2006.01), C07D 403/00 (2006.01), C07D 405/00 (2006.01), C07D 409/00 (2006.01), C07D 411/00 (2006.01), C07D 413/00 (2006.01), C07D 417/00 (2006.01), C07D 419/00 (2006.01), C07D 239/02 (2006.01)
Applicants: SYNTA PHARMACEUTICALS CORP. [US/US]; 45 Hartwell Avenue, Lexington, MA 02421 (US) (For All Designated States Except US).
SUN, Lijun [CN/US]; (US) (For US Only).
CHEN, Shoujun [US/US]; (US) (For US Only).
JIANG, Jun [CN/US]; (US) (For US Only).
XIE, Yu [US/US]; (US).
YU, Chih-yi [--/US]; (US) (For US Only)
Inventors: SUN, Lijun; (US).
CHEN, Shoujun; (US).
JIANG, Jun; (US).
XIE, Yu; (US).
YU, Chih-yi; (US)
Agent: HSI, Jeffrey, D.; Edwards Angell Palmer & Dodge LLP, P.O. Box 55874, Boston, MA 02205 (US)
Priority Data:
60/646,683 25.01.2005 US
Title (EN) COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES
(FR) COMPOSES DESTINES A ETRE UTILISES CONTRE LES INFLAMMATIONS ET LES TROUBLES IMMUNITAIRES
Abstract: front page image
(EN)The invention relates to compounds of structural formula (I) and structural formula (Vl): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R, R1, R2, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
(FR)L'invention concerne des composés de formule structurelle (I) et de formule structurelle (Vl), ou un sel, un solvate, un clathrate, ou un promédicament pharmaceutiquement acceptables desdits composés. Dans lesdites formules R, R1, R2, Z, L et n sont tels que définis dans l'invention. Lesdits composés sont utiles en tant qu'agents immunosuppresseurs ainsi que pour le traitement et la prévention d'états inflammatoires, de troubles allergiques et de troubles immunitaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)